Arrestee Drug Abuse Monitoring (ADAM II)

ICR 201001-3201-002

OMB: 3201-0016

Federal Form Document

Forms and Documents
Document
Name
Status
Supplementary Document
2010-01-13
Supplementary Document
2010-01-11
Supplementary Document
2010-01-11
Supplementary Document
2010-01-11
Supplementary Document
2010-01-11
Supporting Statement B
2010-01-11
Supporting Statement A
2010-01-11
IC Document Collections
IC ID
Document
Title
Status
191750 New
ICR Details
3201-0016 201001-3201-002
Historical Active
ONDCP
Arrestee Drug Abuse Monitoring (ADAM II)
New collection (Request for a new OMB Control Number)   No
Regular
Approved without change 03/15/2010
Retrieve Notice of Action (NOA) 01/14/2010
#
  Inventory as of this Action Requested Previously Approved
03/31/2013 36 Months From Approved
5,000 0 0
1,853 0 0
1,653,540 0 0

A purposive, non-probability sample of sentinel sights (not representative of the US as a whole or individual states or other areas that were not surveyed) that replicates the ADAM methodology in order to obtain data comparable to previously established trends in 10 of the prior ADAM sites. ADAM II implements two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use.

None
None

Not associated with rulemaking

  74 FR 208 10/29/2009
75 FR 1 01/04/2010
No

1
IC Title Form No. Form Name
Arrestee Drug Abuse Monitoring (ADAM II)

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 5,000 0 0 5,000 0 0
Annual Time Burden (Hours) 1,853 0 0 1,853 0 0
Annual Cost Burden (Dollars) 1,653,540 0 0 1,653,540 0 0
Yes
Miscellaneous Actions
No
The increase in Annual Burden from 1667 to 1853 reflects modification in the skip patterns for arrestees who report no recent (past twelve month) drug use. In the original design of the ADAM instrument, the National Institute of Justice was concerned about administering a lengthy interview to arrestees, and decided to exclude arrestees who report no recent illicit drug use from the longer calendar section. This decision was designed to make the ADAM interview (about 20 minutes) as short as feasible and more similar to the older DUF interview (about 10 minutes). However, this has always introduced two problems: loss of important data on all arrestees (housing stability, arrests, incarcerations, drug and psychiatric treatment over the prior year) and confusion in analysis by local users as to whom they were referring (all arrestees or all arrestees admitting use in the prior 12 months). In addition, the skip often produces errors and hesitations in the interview process as the interviewer pauses to check the validity of the skip. In ADAM II the removal of this skip will improve data processing procedures, increase the utility and usability of the data by analysts of all programming skill levels, and will result in a more streamlined personal interview. We anticipate this change will add approximately 2 minutes per calendar line completed for those arrestees who report no drug use in the past 12 months (40% of the total ADAM II sample). On average, we estimate that arrestees who report no recent drug use will be required to complete 3 additional calendar lines, which will result in an overall burden increase of 2.23 minutes per interviewed arrestee (186 annual hours.)

$1,754,862
Yes Part B of Supporting Statement
No
Uncollected
Uncollected
No
Uncollected
Robert Cohen 202-395-5598 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/14/2010


© 2024 OMB.report | Privacy Policy